Webinar: Commercializing the Nu.Q® Vet Cancer Test.

(17:36)

VolitionRx webinar: Unravelling the web of NETs in sepsis … Part II

(56:4)

VolitionRx – Commercializing the Nu.Q Vet Cancer Test: Webinar

(36:37)

VolitionRx webinar: Unravelling the web of NETs in sepsis

(56)

VolitionRx webinar: Breakthrough liquid biopsy method for cancer detection

(50:5)

Webinar - Breakthrough Cancer Detection Method

(23:1econd)

VolitionRx Limited (NYSE American: VNRX) Webcast | Planet MicroCap Showcase: VIRTUAL 2022

(24:34)

VolitionRx Breaks Down Supply Agreement of Nu.Q® Vet Cancer Tests with IDEXX Laboratories

(11:33)

Volition's 2020 Capital Markets Day Video

(1:16:27)

Session 14 - Live Treatment Planning Demonstration 3- Varian student of H\u0026N

(59:39)

Good Reasons to Ignore Valuation by Brian Feroldi

(48:58)

VVS Cardiology Webinar - 'Physical exam... is it cardiac?' with Dr Brigite Pedro

(1:16:31)

2024 MVSS VSIG Webinar

(58:6)

An interview with Cameron Reynolds providing a Volition Update and introduction of New Team Members.

(10:23)

Rethinking the approach to diagnose cancer: VolitionRx Limited (NYSE AMERICAN: VNRX) 重塑癌症診斷方法

(15:51)

VVS Webinar: 'How to Manage Complicated Clinical Endocrine Conundrums' with Professor Rob Foale

(1:23:27)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

Volition webinar: Nu.Q NETs data insights

(57:12)

Volition’s Nu.Q(TM) Vet Assay Detects Two Common Canine Cancers

(2:26)

Unravelling the web of NETs in sepsis - webinar

(41:38)

Revolutionizing the Diagnosis of Life-altering Diseases 為重疾診斷技術帶來革命性突破 | VolitionRx (NYSE-A: VNRX)

(9:26)

Revolutionizing the Diagnosis of Life-altering Diseases - VolitionRx presents at GCFF June, 2022

(16:23)

VolitionRx Limited (NYSE American: VNRX) Webcast | Planet MicroCap Showcase: VEGAS 2023

(28:59)

VolitionRx Ltd. (NYSE MKT: VNRX) Webcast | SNN Network

(24:44)

VolitionRx Discusses $28 Million Licensing Deal with Heska and Focus for 2022

(4:53)

VolitionRX Ltd. (NYSE American: VNRX): Virtual Investor Conferences

(30:10)

VolitionRx Provides Update on Animal Health Blood Test Program, Licensing Deals and Focus for 2021

(10:16)

Business Update and Dr Tom Butera Introduction

(11:50)

Volition (VNRX) NobleCon18 Presentation Replay

(24:56)